Label-free Exosomal Proteomic Detection Service

What Is Label-Free Exosome Proteomics?

Exosomes are nanoscale membrane-bound vesicles released by cells and can carry molecular components such as proteins, lipids, and nucleic acids. Exosome protein composition can be affected by cell origin, physiological state, and experimental treatment. Label-Free Exosome Proteomics uses LC-MS/MS to identify proteins in exosome preparations and performs label-free relative quantification based on peptide chromatographic peak areas or mass spectrometric signal intensities to compare protein abundance changes among different experimental groups.

Relative quantitative comparison of exosome proteins among different experimental groups can be performed without isotopic or chemical labeling. Exosome isolation purity and consistency of sample preparation affect the protein composition entering LC-MS/MS analysis and therefore also affect subsequent protein identification and quantification results. The analysis can provide protein identification, relative quantification, and differential protein information, providing a data basis for subsequent candidate protein screening and further research.

Services at MtoZ Biolabs

Based on a high-resolution LC-MS/MS platform, MtoZ Biolabs integrates exosome sample processing, protein extraction, digestion, and Label-Free quantification into exosome proteomics analysis. Isolated exosomes can proceed to proteomics analysis after sample condition evaluation; source samples that still require exosome isolation can be connected to exosome isolation/purification and subsequent LC-MS/MS according to sample source and study design. Analysis results can include protein identification, relative quantification, and differential proteins, while extended analyses such as functional annotation are determined according to the study design and confirmed analysis content.

When This Service Is a Good Fit

Label-Free Exosome Proteomics is suitable for the following research needs:

• Exosome samples have already been obtained and require protein identification and label-free relative quantification.
• Exosome protein abundance changes need to be compared among different treatment groups, time points, models, or experimental conditions.
• Source samples still require exosome isolation or purification, with exosome preparation followed directly by proteomics analysis.
• A larger number of sample groups need to be analyzed while avoiding limitations associated with isotopic or chemical labeling channel numbers.
• Differential proteins need to be screened from discovery proteomics results to provide candidates for subsequent targeted validation or further research.

Label-Free Exosome Proteomics is mainly used for discovery and comparative proteomics research. Targeted quantification of specific proteins, absolute quantification, and clinical diagnostic conclusions require corresponding analytical methods and additional evidence.

Analysis Workflow

1. Sample and Study Design Evaluation

Confirm sample source, exosome isolation status, sample amount, group design, and research objectives.

2. Exosome Preparation and Sample Quality Evaluation

Source samples that still require exosome isolation undergo exosome isolation/purification according to sample source and study design; for isolated exosomes, existing preparation information and sample condition are evaluated.

3. Exosome Protein Extraction and Digestion

Extract proteins from exosome preparations and perform proteolytic digestion to obtain peptides suitable for LC-MS/MS analysis.

4. LC-MS/MS Analysis

Separate peptides by liquid chromatography and acquire MS and MS/MS data.

5. Protein Identification and Label-Free Quantification

Complete peptide and protein identification and calculate relative protein abundance based on mass spectrometric signals.

6. Differential and Extended Analysis

Perform statistical analysis of differential proteins according to experimental groups; functional annotation or pathway analysis is determined according to the study design and confirmed analysis content.

Figure 1. Label-Free Exosome Proteomics Workflow.

Why Choose MtoZ Biolabs?

1. Exosome Analysis Integration

MtoZ Biolabs can evaluate different starting materials, including source samples, isolated exosomes, exosome protein extracts, and prepared peptides, and connect exosome preparation with subsequent LC-MS/MS analysis according to sample status.

2. High-Resolution LC-MS/MS Platform

MtoZ Biolabs uses high-resolution LC-MS/MS for exosome protein identification and Label-Free relative quantification, providing mass spectrometry analysis support for complex exosome protein samples.

3. Analysis Strategy Evaluation

The MtoZ Biolabs technical team evaluates analysis feasibility and suitable analytical routes according to sample source, exosome isolation status, available sample amount, group design, and research objectives.

4. Results and Data Delivery

Protein identification, relative quantification, differential protein results, analysis reports, and raw mass spectrometry data can be provided; extended analyses are determined according to service applicability.

Sample Submission Suggestions

Submission Status	Information Recommended for Submission
Source samples requiring exosome isolation	Provide sample source, available sample amount, collection/storage information, group design, and research objectives for technical evaluation of exosome preparation and subsequent proteomics analysis.
Isolated exosomes	Provide exosome source, isolation/purification method, storage buffer, available sample amount, and existing quality characterization information, if available.
Exosome protein extracts	Provide the protein extraction method, buffer system, protein amount/concentration, and storage information.
Other preprocessing status	Provide completed sample-processing steps and the remaining sample status so that the technical team can determine whether the samples can proceed directly to subsequent analysis.

Exosome yield, purity, and matrix background vary substantially among different source samples, so a single fixed submission amount is not recommended for a general service page. The actual sample status should be provided before submission so that the MtoZ Biolabs technical team can evaluate sample conditions and analysis feasibility.

Applications

1. Comparative Exosome Proteomics

Compare relative exosome protein abundance among different experimental groups, time points, or treatment conditions and screen differential proteins.

2. Treatment Response Studies

Analyze changes in exosome protein abundance following drug treatment, stimulation, or other experimental interventions.

3. Cell Culture Exosome Studies

Analyze the protein composition of cell culture-derived exosome preparations and changes associated with experimental conditions.

4. Biofluid Exosome Studies

Used for exosome proteomics research on samples derived from plasma, serum, urine, CSF, and other biofluids. Specific feasibility depends on exosome preparation status and sample conditions.

5. Candidate Protein Screening

Screen candidate proteins from differential protein results for subsequent targeted validation or further research.

Deliverables

1. Experimental and Analytical Report

2. Protein Identification Results

3. Protein Relative Quantification Results

4. Statistical Analysis Results for Differential Proteins

5. Functional Annotation or Pathway Analysis Results (If Applicable)

6. Exosome Preparation or Quality Evaluation Results (If Applicable)

7. Raw Mass Spectrometry Data

FAQ

Q1: How many proteins can typically be identified by Label-Free Exosome Proteomics?

The number of proteins identified is affected by sample source, available sample amount, exosome preparation quality, background complexity, protein abundance, and LC-MS/MS analysis conditions. MtoZ Biolabs does not specify a fixed number of protein identifications applicable to all samples. Actual identification results need to be evaluated according to sample status and analysis conditions.

Q2: When is Label-Free more suitable than TMT/iTRAQ or DIA?

The quantitative strategy should be determined according to the number of samples, group design, available sample amount, and comparison objectives. Label-Free is not limited by labeling channel numbers and does not require isotopic or chemical labels; TMT/iTRAQ or DIA are suitable for other quantitative designs. The specific strategy needs to be evaluated according to sample conditions and study design.

Q3: Is exosome characterization required before exosome proteomics analysis?

The need for characterization depends on the submitted material and research objectives. When exosome preparation quality or additional particle information needs to be evaluated, NTA, TEM/Cryo-EM, or marker protein Western blot analysis can be included according to sample status and research needs. Samples with reliable preparation and characterization information can proceed to subsequent proteomics analysis after evaluation.

Q4: Can candidate proteins obtained from discovery analysis undergo further validation?

Further validation strategies can be evaluated according to the candidate proteins, sample matrix, and research objectives. When technically appropriate, PRM targeted mass spectrometry, Western blot, or ELISA can be considered for subsequent validation.

MtoZ Biolabs provides Label-Free Exosome Proteomics Service. For consultation, provide the sample source, exosome isolation status, group design, biological replicates, available sample amount, and research objectives so that the MtoZ Biolabs technical team can evaluate exosome preparation, LC-MS/MS analysis, and data analysis arrangements.